BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 13000273)

  • 41. Chloramphenicol (chloromycetin) in relation to blood dyscrasias with observations on other drugs.
    LEWIS CN; PUTNAM LE; HENDRICKS FD; KERLAN I; WELCH H
    Antibiot Chemother (Northfield); 1952 Dec; 2(12):601-9. PubMed ID: 24542150
    [No Abstract]   [Full Text] [Related]  

  • 42. Aplastic anemia following chloramphenicol therapy in chronic ulcerative colitis: report of a case.
    NUGUID TP; BACON HE
    Dis Colon Rectum; 1961; 4():269-74. PubMed ID: 13729879
    [No Abstract]   [Full Text] [Related]  

  • 43. Chloramphenicol--a new warning.
    DAMESHEK W
    JAMA; 1960 Dec; 174():1853-4. PubMed ID: 13719520
    [No Abstract]   [Full Text] [Related]  

  • 44. [The possibility of pernicious anemia developing into aplastic anemia].
    MUSMECI L
    Policlinico Prat; 1953 Mar; 60(13):454-60. PubMed ID: 13088337
    [No Abstract]   [Full Text] [Related]  

  • 45. [Case of aplastic anemia caused by atabrine].
    RUANO RIESGO R
    Rev Med Costa Rica; 1951 Sep; 10(209):193-8. PubMed ID: 14930413
    [No Abstract]   [Full Text] [Related]  

  • 46. Erythropoietic changes during therapy with chloramphenicol.
    GUSSOFF BD; LEE SL; LICHTMAN HC
    Arch Intern Med; 1962 Feb; 109():176-85. PubMed ID: 13903120
    [No Abstract]   [Full Text] [Related]  

  • 47. Recovery in a case of drug-induced hypoplastic anemia.
    WARD OC; HOLLAND PD
    J Ir Med Assoc; 1960 Jun; 46():165-7. PubMed ID: 13842870
    [No Abstract]   [Full Text] [Related]  

  • 48. [Acute aplastic anemia following atophan medication].
    WISING P
    Sven Lakartidn; 1953 Sep; 50(37):1913-6. PubMed ID: 13102271
    [No Abstract]   [Full Text] [Related]  

  • 49. [Aplastic anemia caused by carbon monoxide poisoning].
    CROIZAT P; REVOL L; FAVRE-GILLY J
    Arch Mal Prof; 1952; 13(2):212-15. PubMed ID: 14953571
    [No Abstract]   [Full Text] [Related]  

  • 50. [Blood complications of medicinal origin. I. The risks of 2 drugs in current use: pyramidon and chloramphenicol].
    LABRAM C
    Concours Med; 1962 Jul; 84():4299-301. PubMed ID: 14461303
    [No Abstract]   [Full Text] [Related]  

  • 51. Aplastic anaemia due to phenylbutazone.
    VENNING GR
    Br Med J; 1957 Jul; 2(5037):146. PubMed ID: 13436883
    [No Abstract]   [Full Text] [Related]  

  • 52. Aplastic anemia following corticotropin therapy.
    SNIVELY GG; HATTERSLEY PG; NOLAN LE
    J Am Med Assoc; 1953 Jul; 152(13):1223-4. PubMed ID: 13061247
    [No Abstract]   [Full Text] [Related]  

  • 53. A case of benzene poisoning.
    SLADE SE
    Arch Middx Hosp; 1953 Jul; 3(3):197-200. PubMed ID: 13081280
    [No Abstract]   [Full Text] [Related]  

  • 54. Aplastic anemia following exposure to carbon tetrachloride.
    STRAUS B
    J Am Med Assoc; 1954 Jun; 155(8):737-9. PubMed ID: 13162791
    [No Abstract]   [Full Text] [Related]  

  • 55. Two cases of fatal pancytopenia following mesantoin therapy.
    SWARTOUT R
    Calif Med; 1953 Feb; 78(2):138-9. PubMed ID: 13019614
    [No Abstract]   [Full Text] [Related]  

  • 56. [Drug-induced aplastic anemia complicated by diabetes mellitus during prednisone therapy].
    HUCZEK-GLEBOCKI J; OSTERCZY Z
    Pol Tyg Lek; 1959 Sep; 14():1662-4. PubMed ID: 14403720
    [No Abstract]   [Full Text] [Related]  

  • 57. Hypoplastic anemia following chronic exposure to kerosene.
    JOHNSON DE
    J Am Med Womens Assoc; 1955 Dec; 10(12):421-4. PubMed ID: 13271176
    [No Abstract]   [Full Text] [Related]  

  • 58. [Repeated blood transfusions in therapy of a case of aplastic anemia in a child caused probably by overdose of chloramphenicol].
    RUCCIA P
    Clin Nuova Rass Prog Med Int; 1952 Apr; 14(17):505-13. PubMed ID: 13067215
    [No Abstract]   [Full Text] [Related]  

  • 59. [Anemia from chloramphenicol].
    JANBON M; BERTRAND L
    Bull Mem Soc Med Hop Paris; 1951 Jun 29-Jul 6; 67(23-24):990-6. PubMed ID: 14870023
    [No Abstract]   [Full Text] [Related]  

  • 60. Fatal pancytopenia following therapy with nuvarone (3-methyl, 5-phenylhydantoin); a case report.
    PEARSON PH; PECK JL; LIVINGSTON S
    Bull Johns Hopkins Hosp; 1952 Nov; 91(5):341-4. PubMed ID: 12987928
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.